logo    Company Page

Most Recent Insiders Activity

Transaction Date Company Name Insider Name (Title) Activity Stock Acquired or Disposed Shares Price range Amount
2024-02-22 OCULAR THERAPEUTIX, INC Dugel Pravin
(Executive Chairman)
A Common Stock A 854979 $0.00 - $0.00 $0
2024-02-22 OCULAR THERAPEUTIX, INC Nayak Sanjay
(Chief Strategy Officer)
A Common Stock A 80300 $0.00 - $0.00 $0
2024-02-05 OCULAR THERAPEUTIX, INC White Christopher G
(Chief Business Officer)
S Common Stock A 5910 $4.86 - $4.86 $28,722
2024-02-03 OCULAR THERAPEUTIX, INC White Christopher G
(Chief Business Officer)
A Common Stock A 39980 $0.00 - $0.00 $0
2024-02-05 OCULAR THERAPEUTIX, INC Strassburger Phil...
(General Counsel)
S Common Stock A 6029 $4.86 - $4.86 $29,300
2024-02-03 OCULAR THERAPEUTIX, INC Strassburger Phil...
(General Counsel)
A Common Stock A 58304 $0.00 - $0.00 $0
2024-02-05 OCULAR THERAPEUTIX, INC Ozden Rabia Gurses
(Chief Medical Officer)
S Common Stock A 6346 $4.86 - $4.86 $30,841
2024-02-03 OCULAR THERAPEUTIX, INC Ozden Rabia Gurses
(Chief Medical Officer)
A Common Stock A 66633 $0.00 - $0.00 $0
2024-02-05 OCULAR THERAPEUTIX, INC Notman Donald
(Chief Financial Officer)
S Common Stock A 6212 $4.86 - $4.86 $30,190
2024-02-03 OCULAR THERAPEUTIX, INC Notman Donald
(Chief Financial Officer)
A Common Stock A 61636 $0.00 - $0.00 $0
2024-02-05 OCULAR THERAPEUTIX, INC Mattessich Antony C.
(President and CEO)
S Common Stock A 19642 $4.86 - $4.86 $95,460
2024-02-03 OCULAR THERAPEUTIX, INC Mattessich Antony C.
(President and CEO)
A Common Stock A 180400 $0.00 - $0.00 $0
2024-01-31 OCULAR THERAPEUTIX, INC Notman Donald
(Chief Financial Officer)
S Common Stock D 6433 $4.95 - $4.95 $31,843
2024-01-31 OCULAR THERAPEUTIX, INC Ozden Rabia Gurses
(Chief Medical Officer)
S Common Stock D 7764 $4.95 - $4.95 $38,431
2024-01-31 OCULAR THERAPEUTIX, INC Strassburger Phil...
(General Counsel)
S Common Stock D 6831 $4.95 - $4.95 $33,813
2024-01-31 OCULAR THERAPEUTIX, INC White Christopher G
(Chief Business Officer)
S Common Stock D 5147 $4.95 - $4.95 $25,477
2024-01-31 OCULAR THERAPEUTIX, INC Mattessich Antony C.
(President and CEO)
S Common Stock D 18338 $4.95 - $4.95 $90,773
logo   

Please upgrade to premium to see all results. Signup if you don't have an account.

Login Signup
Activity types
A Grant, award or other acquisition
C Conversion of Derivative or Security
D Disposition to the issuer of issuer equity securities
E Expiration of short derivative position
F Payment of exercise price or tax liability
G Bona fide Gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary Transaction
J Other acquisition or disposition
K Transaction in equity swap or instrument with similar characteristics
L Small Acquisition
M Exercise or conversion of derivative security
O Exercise of out-of-the-money derivative security
P Open Market Purchase
S Open Market Sale
U Disposition pursuant to a tender of shares in a change of control transaction
V Transaction Voluntarily Reported
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust
Debug Info- Version: 2.6